Proxy advisor ISS recommends Bristol-Myers investors OK Celgene bid

Top proxy adviser Institutional Shareholder Services on Friday recommended Bristol-Myers Squibb shareholders vote in favor of its bid to buy peer biotechnology company Celgene, according to CNBC’s David Faber.

Source link

Leave a Comment

Migrants being held in Texas enclosure as surge overwhelms El PasoObamacare: Has Trump managed to kill off Affordable Care Act?